Trials / Withdrawn
WithdrawnNCT01092689
The Role of Meat-borne Carcinogens in Pancreatic Cancer
Understanding the Role of Meat-Borne Carcinogen in Pancreatic Cancer Etiology
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We propose to recruit subjects scheduled for pancreatectomy as a treatment for pancreatic cancer. These subjects will ingest a very low dose of radiolabeled PhIP, a meat-derived carcinogen, and a small amount of resected tissue (waste) will be analyzed with highly sensitive technology to determine if this carcinogen binds to DNA in the pancreas.
Detailed description
Pancreatic cancer is rapidly fatal in most cases and little is known about its causes. Identifying and modifying risk factors can reduce mortality through prevention. Carcinogens that form in meat cooked at high temperatures may be modifiable risk factors for pancreatic cancer, but direct evidence is needed to demonstrate involvement in pancreas tissue. We propose to recruit subjects scheduled for pancreatectomy as a treatment for pancreatic cancer. These subjects will ingest a very low dose of radiolabeled PhIP, a meat-derived carcinogen, and a small amount of resected tissue (waste) will be analyzed with highly sensitive technology to determine if this carcinogen binds to DNA in the pancreas. We hypothesize that the meat-derived carcinogen will bind to DNA in the pancreas. The amount of PhIP ingested is equivalent to the amount in two very well-done barbecued chicken breasts and the dose of radioactivity is comparable to a typical chest x-ray. This research can increase understanding of pancreatic carcinogenesis, facilitating the design of prevention strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PhiP | 1 capsule of 84 micrograms; 15.6 micro-curies \[14C\]PhIP |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-03-25
- Last updated
- 2020-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01092689. Inclusion in this directory is not an endorsement.